Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Meiragtx Holdings Plc (MGTX)
NASDAQ:MGTX
Holding MGTX?
Track your performance easily
MGTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.49 - $7.60
Previous Close$4.29
Volume124.88K
Average Volume (3M)199.28K
Market Cap
$332.04M
Enterprise Value$319.63M
Total Cash (Recent Filing)$99.97M
Total Debt (Recent Filing)$87.56M
Price to Earnings (P/E)―
Beta1.75
Next Earnings
Nov 07, 2024EPS Estimate
-$0.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.50
Shares Outstanding77,180,000
10 Day Avg. Volume194,658
30 Day Avg. Volume199,285
Standard Deviation0.18
R-Squared0.14
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)4.11
Price to Sales (P/S)39.91
Price to Cash Flow (P/CF)-4.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue39.35
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.37
Forecast
1Y Price Target
$22.50Price Target Upside424.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Meiragtx Holdings News
Ownership Overview
30.82% Insiders
3.87% Mutual Funds
45.23% Other Institutional Investors
20.09% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MGTX FAQ
What was Meiragtx Holdings Plc’s price range in the past 12 months?
Meiragtx Holdings Plc lowest stock price was $3.49 and its highest was $7.60 in the past 12 months.
What is Meiragtx Holdings Plc’s market cap?
Currently, no data Available
When is Meiragtx Holdings Plc’s upcoming earnings report date?
Meiragtx Holdings Plc’s upcoming earnings report date is Nov 07, 2024 which is in 48 days.
How were Meiragtx Holdings Plc’s earnings last quarter?
Meiragtx Holdings Plc released its earnings results on Aug 12, 2024. The company reported -$0.76 earnings per share for the quarter, missing the consensus estimate of -$0.4 by -$0.36.
Is Meiragtx Holdings Plc overvalued?
According to Wall Street analysts Meiragtx Holdings Plc’s price is currently Undervalued.
Does Meiragtx Holdings Plc pay dividends?
Meiragtx Holdings Plc does not currently pay dividends.
What is Meiragtx Holdings Plc’s EPS estimate?
Meiragtx Holdings Plc’s EPS estimate is -$0.53.
How many shares outstanding does Meiragtx Holdings Plc have?
Meiragtx Holdings Plc has 77,398,920 shares outstanding.
What happened to Meiragtx Holdings Plc’s price movement after its last earnings report?
Meiragtx Holdings Plc reported an EPS of -$0.76 in its last earnings report, missing expectations of -$0.4. Following the earnings report the stock price went down -8.467%.
Which hedge fund is a major shareholder of Meiragtx Holdings Plc?
Among the largest hedge funds holding Meiragtx Holdings Plc’s share is Perceptive Advisors LLC. It holds Meiragtx Holdings Plc’s shares valued at 48M.
---
Meiragtx Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$22.50 (424.48% Upside)
$22.50 (424.48% Upside)
Blogger Sentiment
Bullish
MGTX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 30.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $5.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 4.4%
Last 30 Days ▲ 4.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.07%
12-Months-Change
Fundamentals
Return on Equity
-91.51%
Trailing 12-Months
Asset Growth
-14.06%
Trailing 12-Months
Company Description
Meiragtx Holdings Plc
MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.
---
MGTX Stock 12 Month Forecast
Average Price Target
$22.50
▲(424.48% Upside)
Technical Analysis
Adaptimmune Therapeutics
―
Clearside Biomedical
―
Fate Therapeutics
―
Oncternal Therapeutics
―
Best Analysts Covering MGTX
1 Year
1 Year Success Rate
3/16 ratings generated profit
1 Year Average Return
-21.74%
assigned a buy rating last month
Copying Luca Issi's trades and holding each position for 1 Year would result in 18.75% of your transactions generating a profit, with an average return of -21.74% per trade.
---